Underexpression of RhoH in hairy cell leukemia

28Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

The cause of hairy cell leukemia (HCL) is unknown. Current treatments seem effective only for a limited period of time. In addition, a significant proportion of patients remain refractive to all treatment options. These considerations indicate the need to develop alternative therapeutic strategies for HCL. Here, we report that HCL is characterized by underexpression of RhoH. In vitro reconstitution of RhoH expression inhibits the aberrant adhesion and transendothelial migration that drives disease pathogenesis. In an in vivo model of HCL, RhoH reconstitution limits malignant progression and protects against mortality. These findings provide the proof of principle that RhoH reconstitution represents a potential new approach to the treatment of HCL. ©2008 American Association for Cancer Research.

Cite

CITATION STYLE

APA

Galiègue-Zouitina, S., Delestré, L., Dupont, C., Troussard, X., & Shelley, C. S. (2008). Underexpression of RhoH in hairy cell leukemia. Cancer Research, 68(12), 4531–4540. https://doi.org/10.1158/0008-5472.CAN-07-5661

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free